Silver Book Fact

One-Year Cost Component for Atrial Fibrillation & Non AF Medicare Patients

Fact image

One-Year Cost Component for AF & Non AF Medicare Patients

Lee W, Lamas G, Balu S, Spalding J, et al. Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective. J Med Econ. 2008; 11(2): 281-98. http://www.ncbi.nlm.nih.gov/pubmed/19450086

Reference

Title
Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective
Publication
J Med Econ
Publication Date
2008
Authors
Lee W, Lamas G, Balu S, Spalding J, et al.
Volume & Issue
Volume 11, Issue 2
Pages
281-98
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Risk of ischemic stroke in AFib patients
    The risk of ischemic stroke in nonvalvular atrial fibrillation patients is 2 to 7 times (200% to 700%) greater than in those without the disease.  
  • Hospital costs for ischemic stroke
    Hospital costs for nonrecurrent ischemic stroke are 20% higher in patients with atrial fibrillation, than in patients without the disease.  
  • Healthcare costs of atrial fibrillation
    Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations…  
  • Age as a risk factor of Afib
    At age 60, 1 in 25 Americans have AFib. At age 80+, this increases to nearly 1 in 10.  
  • AFib prevalence, 2006
    As much as 1% of the U.S. population is estimated to have atrial fibrillation